Challenges With CAR T-Cell Therapies in T-Cell Lymphomas

Jasmine M. Zain, MD, of City of Hope, discuss challenges in CAR-T therapies in patients with T-cell lymphomas.

Related Content:

City of HopeCAR T-cell TherapyNon-Hodgkin Lymphoma

Dr Amanam on the Optimal Use of JAK Inhibitors in the Current Myelofibrosis Treatment Paradigm

Clinical Scenario: Locally Recurrent NPC

Integrating PD-1 Inhibitors into Standard NPC Treatment: Potential Benefits and Future Prospects